On April 23, 2024, the U.S. Department of Labor (DOL) issued its final rule significantly increasing the compensation thresholds that must be met for…...
The Philippine Stock Exchange (PSE) implemented the PSE Short-Selling Program on November 6, 2023, following the effectivity of the PSE Guidelines for…...
The Korean Biomedical Review has reported that Samil Pharmaceutical will launch Samsung Bioepis’ aflibercept in Korean market from 1 May 2024. Samil…...
In the competitive landscape of modern business, Intellectual Property (IP) rights are a crucial safeguard to preserving innovations and investments…...